Data from a Johns Hopkins Medicine-led analysis provide insight into the risk of cardiovascular complications among women with polycystic ovary syndrome during delivery hospitalizations compared to their counterparts without PCOS.
Data presented at the European Congress of Endocrinology detail genetic and observational associations between obesity, and markers of body composition on the likelihood of developing PCOS later in life.
Results of a recent study shed light on observational and genetic associations between obesity and multiple female reproductive disorders, including uterine fibroids, PCOS, and heavy menstrual bleeding.
A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.
Data from a phase 2 study of women with overweight or obesity and polycystic ovary syndrome suggests use of licogliflozin was associated with significant reductions in hyperinsulinemia and androgenemia in this patient population.